Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Monoclonal antibody anti-CGRP NCT06459648 · PREDI-CGRP — Study for Prevent Chronification Migraine Through Prediction of Res… | Migraine | À vérifier | À vérifier | RECRUITING | Being able to predict each patients response to a specific treatment can m… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:08 | Détail |
| Serotonergic Psychedelic NCT06624137 · Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics | Migraine | Thérapie génique | À vérifier | TERMINATED | This is an observational study which does NOT directly administer a psyche… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:08 | Détail |
| MRI NCT05654012 · Migraine in Adolescents | Migraine | Remyélinisation · Thérapie génique | Non applicable | RECRUITING | The cognitive disorders of adult forms of myotonic dystrophies type 1 are… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Psilocybin NCT06464367 · Mechanistic Studies of Psilocybin in Headache Disorders | Migraine | À vérifier | Phase 1 | RECRUITING | This study aims to study the feasibility of psilocybin therapy for patient… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Rimegepant NCT06641466 · A Study to Learn About the Study Medicine Called Rimegepant in Women When Used f… | Migraine | À vérifier | Phase 3 | RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Tear Biomarkers for Migraine NCT07690696 · NCT07690696 | Migraine | À vérifier | À vérifier | NOT_YET_RECRUITING | The goal of this observational monocentric study is to investigate tear an… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Thermal stimuli NCT05738213 · IHS — Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine | Migraine | Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | The purpose of this research study is to investigate the relationships bet… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Thermal stimuli NCT06785129 · EMC — Endometriosis and Migraine | Migraine | Traitement symptomatique | À vérifier | RECRUITING | The purpose of this research study is to investigate the relationships bet… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Yangxue Qingnao Granules (Pills) NCT05334927 · CHAIRS — China HeadAche DIsorders RegiStry | Migraine | À vérifier | À vérifier | RECRUITING | It is planned to include 10000 patients. In the China HeadAche DIsorders R… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:07 | Détail |
| Transcranial Direct Current stimulation NCT06401928 · Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Scl… | Sclérose en plaques | Traitement symptomatique | Non applicable | COMPLETED | Migraine is a common, heterogeneous neurological disorder affecting approx… À vérifier | ClinicalTrials.gov 2026-08-13 14:27:41 | Détail |
| Anodal Transcranial direct current stimulation NCT01752439 · Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migrain… | Migraine | À vérifier | Non applicable | UNKNOWN | This research is being done to determine whether transcranial direct curre… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| BOTOX NCT00660192 · Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) i… | Migraine | Thérapie génique | Phase 2 | COMPLETED | Migraine is a neurological disease characterized by moderate or severe hea… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Dexamethasone, Lidocaine, Thiamine cohort NCT03220113 · Treatment of Chronic Migraine Headaches. | Migraine | Traitement symptomatique | Phase 1 | UNKNOWN | The purpose of the study is assessment of the safety and efficacy of the D… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Erenumab Auto-Injector NCT04152434 · Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy | Migraine | À vérifier | À vérifier | COMPLETED | Treatment of chronic migraineurs who have failed more than 3 preventive dr… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| ketamine infusion NCT06935552 · Ketamine and Lidocaine Infusion in Refractory Chronic Migraine | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 1 | NOT_YET_RECRUITING | Ketamine is a drug used for anesthesia but at low doses it is a very effec… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Ketorolac NCT04353505 · Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headac… | Migraine | À vérifier | Phase 1 | WITHDRAWN | The purpose of this study is to evaluate the safety and efficacy of intra-… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Lidocaine (drug) NCT07361549 · LIGHT 2 — Localized Injection of Lidocaine Via the Middle Meningeal Artery for I… | Migraine | Traitement symptomatique | Phase 2 | NOT_YET_RECRUITING | The main purpose of this study is to evaluate the effectiveness of a new t… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Middle Meningeal Artery embolization NCT06029153 · FAST-EM — Efficacy and Safety of Middle Meningeal Artery Embolization for Treatm… | Migraine | À vérifier | Non applicable | COMPLETED | This is a prospective, multi-center, feasibility study to investigate safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Precision NCT00747812 · PRISM UK — Study of Occipital Nerve Stimulation for Drug Refractory Migraine | Migraine | Thérapie génique | Phase 2 | TERMINATED | The purpose of this study is to evaluate the safety and effectiveness of a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
| Precision NCT00286078 · Treatment for Migraines With an Implantable Device | Migraine | Thérapie génique | Non applicable | COMPLETED | The purpose of this study is to evaluate the safety and effectiveness of a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:17 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| The impact of timing, dosage, and duration of high-dose methylprednis… Methylprednisolone sodium succinate · PMID 42240612 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The role of high-dose methylprednisolone sodium succinate (MPSS) in acute traumatic spinal cord injury (SCI) remains co… | The journal of spinal cord medicine 2026-08-08 01:00:09 | Source |
| Exploring the Sensitivity Limits of Neuronal Current Imaging With MRI… Visual Stimulation · PMID 42565248 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Conventional BOLD-fMRI relies on hemodynamic responses that are temporally and spatially indirect markers of neural act… | Human brain mapping 2026-08-08 01:00:07 | Source |
| Investigating the Time-Course of Verticality Sensitivity Changes Duri… Visual Stimulation · PMID 42562383 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Verticality perception is a multisensory process that relies primarily on visual and vestibular input. Previous studies… | Multisensory research 2026-08-08 01:00:07 | Source |
| Evaluating clinical associations of immediate post-traumatic headache… Prospective ED Headache Cohort Study · PMID 42563150 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Post-traumatic headache (PTH) is a frequent early consequence of head traumatic injury, yet emergency departments (EDs)… | The journal of headache and pain 2026-08-08 01:00:06 | Source |
| Retinal layers prognosticate cognitive progression independent of rel… Prospective ED Headache Cohort Study · PMID 42562954 | Migraine | Neuroprotection · Ralentissement de la progression · Thérapie génique | Publication | PubMed | Voir la publication source Optical coherence tomography (OCT) quantifies retinal neuroaxonal loss related to neurodegeneration in people with mult… | Journal of neurology 2026-08-08 01:00:06 | Source |
| Chronic xenogeneic GVHD after CAR T cell therapy limits long-term saf… antibodies against calcitonin-gene related peptide or its receptor · PMID 42566762 | Migraine | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source The clinical successes of chimeric antigen receptor (CAR) T cells represent a major shift in immunotherapy. However, th… | Blood advances 2026-08-08 01:00:05 | Source |
| Comparative analyses of olfactory receptor repertoires in Schizothora… antibodies against calcitonin-gene related peptide or its receptor · PMID 42566844 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The olfactory receptor (OR) genes constitute the molecular basis of fish olfaction, mediating survival behaviors and en… | Comparative biochemistry and physiology. Part D, Genom… 2026-08-08 01:00:05 | Source |
| Digital Remote Assessment of Motor and Speech Changes in Amyotrophic… Click Digital Therapeutic · PMID 42531420 | Migraine | Ralentissement de la progression · Thérapie génique | Publication | PubMed | Voir la publication source Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an active trial landscape that relies on the se… | JMIR formative research 2026-08-08 01:00:04 | Source |
| Short dextran-solanesol block copolymer as a bio-based platform for m… Click Digital Therapeutic · PMID 42493094 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Biohybrid block copolymer micelles from natural components hold great promise for biomedical applications; however, int… | Carbohydrate polymers 2026-08-08 01:00:04 | Source |
| Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PA… MEDI0618 · PMID 40036725 | Migraine | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Protease activated receptor 2 (PAR2) is a G-protein coupled receptor expressed in meningeal neurons, fibroblasts and ma… | Brain : a journal of neurology 2026-08-08 01:00:03 | Source |
| The development of proteinase-activated receptor-2 modulators and the… MEDI0618 · PMID 33242065 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the adva… | Biochemical Society transactions 2026-08-08 01:00:03 | Source |
| Delivery Model Matters for Digital Interventions in Pain Self-Managem… Care as usual · PMID 42475133 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Digital health interventions can improve access to and outreach of evidence-based support for people living with chroni… | Journal of medical Internet research 2026-08-08 01:00:02 | Source |
| Process Evaluation of a Problem-Solving Intervention with Workplace I… Care as usual · PMID 42541653 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This process evaluation examined the implementation of a problem-solving intervention with workplace involvement (PSI-W… | Journal of occupational rehabilitation 2026-08-08 01:00:02 | Source |
| Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia: A Randomiz… Ultrasound guided Stellate ganglion block · PMID 42530408 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Fibromyalgia is a chronic pain syndrome characterized by widespread pain, fatigue, and sleep disturbance. Many patients… | Pain research & management 2026-08-08 01:00:00 | Source |
| Post-dural Puncture Headache During Bacteraemia: Successful Managemen… ultrasound guided Greater occipital nerve block · PMID 42535063 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Epidural blood patch (EBP) is considered the most effective interventional treatment for post-dural puncture headache (… | Cureus 2026-08-08 00:59:59 | Source |
| Ultrasound-Guided Greater Occipital Nerve Block Across Headache Pheno… ultrasound guided Greater occipital nerve block · PMID 42533183 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Greater occipital nerve blocks (GONBs) are used across headache phenotypes, but short-term effectiveness and predictors… | Pain and therapy 2026-08-08 00:59:59 | Source |
| CGRP-pathway exposure during the pre-EBP interval in spontaneous intr… Galcanezumab · PMID 42432562 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Given hypothesized involvement of calcitonin gene-related peptide (CGRP) in trigeminovascular pain and the frequent mig… | BMC neurology 2026-08-08 00:59:58 | Source |
| Comparing synthetic and biological therapy for the treatment of clust… Galcanezumab · PMID 42493477 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Cluster headache is an extremely painful and severely disabling primary headache disorder that, despite its profound im… | Expert review of neurotherapeutics 2026-08-08 00:59:58 | Source |
| Compound Chamomile and Lidocaine Hydrochloride Gel in Oral Diseases:… Lidocaine Hydrochloride · PMID 42558651 | Migraine | Immunomodulation · Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Oral diseases frequently entail microbial infections or mucosal damage, typically accompanied by pain and discomfort. P… | Drug design, development and therapy 2026-08-08 00:59:57 | Source |
| Impact of Menthol Concentration on Ketoprofen Permeation and Photosta… Lidocaine Hydrochloride · PMID 42518428 | Migraine | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Topical nonsteroidal anti-inflammatory drugs provide localized pain relief while reducing the risk of systemic adverse… | ACS omega 2026-08-08 00:59:57 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |